BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29126497)

  • 1. Radiation Therapy for Oral Cavity and Oropharyngeal Cancers.
    Lin A
    Dent Clin North Am; 2018 Jan; 62(1):99-109. PubMed ID: 29126497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
    Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second head and neck cancers following radiation therapy of T1 and T2 cancers of the oral cavity and oropharynx.
    Fijuth J; Mazeron JJ; Le Péchoux C; Piedbois P; Martin M; Haddad E; Calitchi E; Pierquin B; Le Bourgeois JP
    Int J Radiat Oncol Biol Phys; 1992; 24(1):59-64. PubMed ID: 1512164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: a review of recent techniques.
    Janjan NA; Campbell B; Wilson JF; Toohill R
    Cancer Treat Rev; 1990 Mar; 17(1):89-101. PubMed ID: 2224871
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients: acute response to radiation therapy.
    Kao GD; Devine P; Mirza N
    Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):873-6. PubMed ID: 10448734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
    Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
    Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life efficacy of volumetric modulated arc therapy in head and neck squamous cell carcinoma.
    Moncharmont C; Vallard A; Guy JB; Prades JM; Rancoule C; Magné N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 May; 134(3):165-169. PubMed ID: 28034705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pencil beam scanning proton therapy vs rotational arc radiation therapy: A treatment planning comparison for postoperative oropharyngeal cancer.
    Apinorasethkul O; Kirk M; Teo K; Swisher-McClure S; Lukens JN; Lin A
    Med Dosim; 2017 Spring; 42(1):7-11. PubMed ID: 27839693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Description of the GORTEC 2017-03 study: Postoperative stereotactic radiotherapy for early stage oropharyngeal and oral cavity cancer with high risk margin (PHRC-K-16-164)].
    Biau J; Miroir J; Millardet C; Saroul N; Pham-Dang N; Racadot S; Huguet F; Kwiatkowski F; Pereira B; Bourhis J; Lapeyre M
    Cancer Radiother; 2017 Oct; 21(6-7):527-532. PubMed ID: 28865970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in telomerase activity of advanced cancers of oral cavity and oropharynx during radiation therapy: correlation with clinical outcome.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Int J Mol Med; 1998 Sep; 2(3):301-7. PubMed ID: 9855702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in radiation oncology for the management of oropharyngeal tumors.
    Gunn GB; Frank SJ
    Otolaryngol Clin North Am; 2013 Aug; 46(4):629-43. PubMed ID: 23910474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.
    Owosho AA; Tsai CJ; Lee RS; Freymiller H; Kadempour A; Varthis S; Sax AZ; Rosen EB; Yom SK; Randazzo J; Drill E; Riedel E; Patel S; Lee NY; Huryn JM; Estilo CL
    Oral Oncol; 2017 Jan; 64():44-51. PubMed ID: 28024723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reconstructive surgery and organ-sparing methods in the treatment of patients with laryngeal and oral cavity tumors].
    Matiakin EG; Alferov VS; Uvarov AA; Fedotenko SP; Dubitskaia TK; Zak EM; Isakov VF; Kropotov MA; Shelina VN
    Vestn Ross Akad Med Nauk; 1995; (4):30-3. PubMed ID: 7780339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of relapse following surgery and postoperative intensity modulated radiotherapy for oral and oropharyngeal cancer.
    Collan J; Lundberg M; Vaalavirta L; Bäck L; Kajanti M; Mäkitie A; Tenhunen M; Saarilahti K
    Acta Oncol; 2011 Oct; 50(7):1119-25. PubMed ID: 21247264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)].
    Lapeyre M; Henrot P; Alfonsi M; Bardet E; Bensadoun RJ; Dolivet G; Favrel V; Gallocher O; Giraud P; Graff P; Guerif S; Lagarde P; Lartigau E; Marchesi V; Pommier P; Rives M; Tortochaux J; Toussaint B; Verrelle P; Bourhis J; Calais G;
    Cancer Radiother; 2005 Jun; 9(4):261-70. PubMed ID: 16081023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma.
    Yao M; Karnell LH; Funk GF; Lu H; Dornfeld K; Buatti JM
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1354-60. PubMed ID: 17689885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mandibular osteoradionecrosis in squamous cell carcinoma of the oral cavity and oropharynx: incidence and risk factors.
    Monnier Y; Broome M; Betz M; Bouferrache K; Ozsahin M; Jaques B
    Otolaryngol Head Neck Surg; 2011 May; 144(5):726-32. PubMed ID: 21493361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers.
    Moon DH; Moon SH; Wang K; Weissler MC; Hackman TG; Zanation AM; Thorp BD; Patel SN; Zevallos JP; Marks LB; Chera BS
    Oral Oncol; 2017 Sep; 72():98-103. PubMed ID: 28797468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delineation for oral cavity and oropharyngeal cancers].
    Lapeyre M; Loos G; Biau J
    Cancer Radiother; 2013 Oct; 17(5-6):493-7. PubMed ID: 23973455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
    Dirix P; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.